Cancer diagnostics and therapies have improved steadily over the last few decades,
markedly increasing life expectancy for patients at all ages. However, conventional and …

Although significant improvements have been made in the outcomes of children with cancer,
the pace of improvement has slowed in recent years as the limits of therapy intensification …

Anthracyclines are one of the most effective chemotherapy agents and have revolutionized
cancer therapy. However, anthracyclines can induce cardiac injuries through 'multiple-hits' …

Cardiovascular disease is a leading cause of death in cancer survivors. It is critical to apply
new predictive and early diagnostic methods in this population, as this can potentially inform …

Both cancer treatment and survival have significantly improved, but these advances have
highlighted the deleterious effects of vascular complications associated with anticancer …

Advances in chemotherapy and supportive therapy have resulted in improved clinical
outcomes in patients with hematological malignancies undergoing hematopoietic stem-cell …

Since their introduction in the 1960s, anthracyclines have been a significant breakthrough in
oncology, introducing dramatic changes in the treatment of solid and hematologic …

Cancer is one of the leading causes of morbidity and mortality in the pediatric population
with the most common cancer being acute lymphoblastic leukemia. One of the most common …

Background Cardiotoxicity is among the most important adverse effects of childhood cancer
treatment. Anthracyclines, mitoxantrone and radiotherapy involving the heart are its main …

Improving cancer survival represents the most significant effect of precision medicine and
personalized molecular and immunologic therapeutics. Cardiovascular health becomes …